Pitcairn’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-18,553
| Closed | -$2.06M | – | 219 |
|
|
2025
Q3 | $2.06M | Sell |
18,553
-3,734
| -17% | -$424K | 0.16% | 115 |
|
|
2025
Q2 | $2.47M | Buy |
22,287
+11,104
| +99% | +$1.18M | 0.16% | 118 |
|
|
2025
Q1 | $1.25M | Buy |
11,183
+4,338
| +63% | +$448K | 0.08% | 229 |
|
|
2024
Q4 | $632K | Buy |
6,845
+265
| +4% | +$23.9K | 0.04% | 361 |
|
|
2024
Q3 | $552K | Sell |
6,580
-1,600
| -20% | -$122K | 0.03% | 410 |
|
|
2024
Q2 | $561K | Buy |
8,180
+550
| +7% | +$36.7K | 0.03% | 411 |
|
|
2024
Q1 | $559K | Sell |
7,630
-6,475
| -46% | -$498K | 0.04% | 405 |
|
|
2023
Q4 | $1.14M | Sell |
14,105
-1,641
| -10% | -$128K | 0.08% | 219 |
|
|
2023
Q3 | $1.18M | Sell |
15,746
-467
| -3% | -$35.9K | 0.1% | 185 |
|
|
2023
Q2 | $1.25M | Sell |
16,213
-2,175
| -12% | -$173K | 0.11% | 171 |
|
|
2023
Q1 | $1.53M | Buy |
18,388
+11,837
| +181% | +$980K | 0.14% | 139 |
|
|
2022
Q4 | $562K | Buy |
6,551
+1,006
| +18% | +$79.7K | 0.06% | 293 |
|
|
2022
Q3 | $342K | Sell |
5,545
-196
| -3% | -$12.4K | 0.04% | 380 |
|
|
2022
Q2 | $355K | Buy |
5,741
+43
| +0.8% | +$2.66K | 0.04% | 386 |
|
|
2022
Q1 | $339K | Sell |
5,698
-1,264
| -18% | -$80.8K | 0.03% | 472 |
|
|
2021
Q4 | $506K | Buy |
6,962
+67
| +1% | +$4.62K | 0.03% | 367 |
|
|
2021
Q3 | $482K | Sell |
6,895
-370
| -5% | -$26K | 0.03% | 361 |
|
|
2021
Q2 | $500K | Sell |
7,265
-730
| -9% | -$48.7K | 0.03% | 342 |
|
|
2021
Q1 | $517K | Buy |
7,995
+12
| +0.2% | +$774 | 0.04% | 319 |
|
|
2020
Q4 | $465K | Sell |
7,983
-466
| -6% | -$28.1K | 0.04% | 301 |
|
|
2020
Q3 | $534K | Sell |
8,449
-2,065
| -20% | -$143K | 0.05% | 248 |
|
|
2020
Q2 | $809K | Buy |
10,514
+622
| +6% | +$47.7K | 0.08% | 161 |
|
|
2020
Q1 | $740K | Buy |
9,892
+1,130
| +13% | +$78.1K | 0.09% | 138 |
|
|
2019
Q4 | $569K | Sell |
8,762
-904
| -9% | -$58.9K | 0.05% | 235 |
|
|
2019
Q3 | $612K | Sell |
9,666
-1,574
| -14% | -$103K | 0.06% | 205 |
|
|
2019
Q2 | $759K | Buy |
11,240
+2,083
| +23% | +$137K | 0.08% | 165 |
|
|
2019
Q1 | $595K | Sell |
9,157
-5,988
| -40% | -$398K | 0.06% | 195 |
|
|
2018
Q4 | $947K | Sell |
15,145
-13,485
| -47% | -$943K | 0.1% | 117 |
|
|
2018
Q3 | $2.21M | Sell |
28,630
-4,925
| -15% | -$372K | 0.23% | 54 |
|
|
2018
Q2 | $2.38M | Sell |
33,555
-528
| -2% | -$37.3K | 0.25% | 50 |
|
|
2018
Q1 | $2.57M | Buy |
34,083
+1,662
| +5% | +$132K | 0.27% | 44 |
|
|
2017
Q4 | $2.32M | Sell |
32,421
-1,397
| -4% | -$106K | 0.23% | 53 |
|
|
2017
Q3 | $2.74M | Sell |
33,818
-2,310
| -6% | -$177K | 0.31% | 44 |
|
|
2017
Q2 | $2.56M | Buy |
36,128
+16,897
| +88% | +$1.12M | 0.31% | 42 |
|
|
2017
Q1 | $1.31M | Buy |
19,231
+5,207
| +37% | +$366K | 0.16% | 98 |
|
|
2016
Q4 | $1M | Buy |
14,024
+904
| +7% | +$67.2K | 0.12% | 124 |
|
|
2016
Q3 | $1.04M | Buy |
13,120
+641
| +5% | +$52.1K | 0.13% | 124 |
|
|
2016
Q2 | $1.04M | Sell |
12,479
-103
| -0.8% | -$9.14K | 0.13% | 111 |
|
|
2016
Q1 | $1.16M | Sell |
12,582
-151
| -1% | -$13.6K | 0.15% | 120 |
|
|
2015
Q4 | $1.29M | Buy |
12,733
+147
| +1% | +$15.3K | 0.14% | 106 |
|
|
2015
Q3 | $1.24M | Sell |
12,586
-12,787
| -50% | -$1.42M | 0.16% | 104 |
|
|
2015
Q2 | $2.97M | Sell |
25,373
-2,854
| -10% | -$312K | 0.34% | 47 |
|
|
2015
Q1 | $2.77M | Sell |
28,227
-3,858
| -12% | -$392K | 0.31% | 57 |
|
|
2014
Q4 | $3.02M | Sell |
32,085
-952
| -3% | -$98.5K | 0.33% | 51 |
|
|
2014
Q3 | $3.52M | Buy |
33,037
+2,301
| +7% | +$225K | 0.39% | 39 |
|
|
2014
Q2 | $2.55M | Buy |
30,736
+2,754
| +10% | +$214K | 0.28% | 65 |
|
|
2014
Q1 | $1.98M | Buy |
27,982
+763
| +3% | +$59.8K | 0.22% | 80 |
|
|
2013
Q4 | $2.04M | Buy |
27,219
+402
| +1% | +$28K | 0.23% | 80 |
|
|
2013
Q3 | $1.69M | Buy |
26,817
+4,641
| +21% | +$277K | 0.21% | 93 |
|
|
2013
Q2 | $1.14M | Buy |
+22,176
| New | +$1.16M | 0.15% | 131 |
|
Other funds holding GILD
Pitcairn's GILD Position: Q4 2025 in Review
Pitcairn sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 18,553 shares — an estimated $2.06M sold.
Pitcairn first reported a position in GILD in Q2 2013 and held it in 50 quarters. The position peaked at $3.52M in Q3 2014. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- Pitcairn reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
- Pitcairn sold 18,553 Gilead Sciences shares in Q4 2025, an estimated $2.06M.
- Pitcairn first reported a position in Gilead Sciences in Q2 2013 and held it in 50 quarters.
- Pitcairn's Gilead Sciences position peaked at $3.52M in Q3 2014.
- 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on Pitcairn's 13F filing for Q4 2025.